Noncholesterol Sterols and Sitosterolemia in Clinical Practice
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Verges B, Fumeron F
. Potential risks associated with increased plasma plant-sterol levels. Diabetes Metab. 2014; 41(1):76-81.
DOI: 10.1016/j.diabet.2014.11.003.
View
2.
Yoshida H, Tada H, Ito K, Kishimoto Y, Yanai H, Okamura T
. Reference Intervals of Serum Non-Cholesterol Sterols by Gender in Healthy Japanese Individuals. J Atheroscler Thromb. 2019; 27(5):409-417.
PMC: 7242229.
DOI: 10.5551/jat.50187.
View
3.
Assmann G, Kannenberg F, Ramey D, Musliner T, Gutkin S, Veltri E
. Effects of ezetimibe, simvastatin, atorvastatin, and ezetimibe-statin therapies on non-cholesterol sterols in patients with primary hypercholesterolemia. Curr Med Res Opin. 2007; 24(1):249-59.
DOI: 10.1185/030079908x253663.
View
4.
Dayspring T, Varvel S, Ghaedi L, Thiselton D, Bruton J, McConnell J
. Biomarkers of cholesterol homeostasis in a clinical laboratory database sample comprising 667,718 patients. J Clin Lipidol. 2015; 9(6):807-816.
DOI: 10.1016/j.jacl.2015.08.003.
View
5.
Mori K, Ishida T, Tsuda S, Oshita T, Shinohara M, Hara T
. Enhanced Impact of Cholesterol Absorption Marker on New Atherosclerotic Lesion Progression After Coronary Intervention During Statin Therapy. J Atheroscler Thromb. 2016; 24(2):123-132.
PMC: 5305673.
DOI: 10.5551/jat.32615.
View